作者: Aliesha L Griffin , Priyadarshini Jaishankar , Jean-Marc Grandjean , Steven H Olson , Adam R Renslo
DOI: 10.1093/BRAINCOMMS/FCZ008
关键词: Clemizole 、 Serotonin 、 5-HT receptor 、 Fenfluramine 、 Drug development 、 Trazodone 、 Receptor 、 Medicine 、 Pharmacology 、 Dravet syndrome
摘要: Dravet syndrome is a life-threatening early-onset epilepsy not well controlled by antiepileptic drugs. Drugs that modulate serotonin (5-HT) signalling, including clemizole, locaserin, …